Insufficient scRNA-seq data for expression of PCDHB3 at single-cell level.
Insufficient scRNA-seq data for expression of PCDHB3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 99% | 88.42 | 243 / 245 | 71% | 4.87 | 354 / 502 |
| brain | 95% | 70.57 | 2516 / 2642 | 72% | 5.19 | 509 / 705 |
| breast | 100% | 179.60 | 459 / 459 | 63% | 3.38 | 707 / 1118 |
| pancreas | 95% | 74.28 | 311 / 328 | 65% | 1.56 | 116 / 178 |
| kidney | 99% | 95.49 | 88 / 89 | 61% | 3.74 | 548 / 901 |
| ovary | 100% | 166.91 | 180 / 180 | 57% | 4.41 | 243 / 430 |
| lung | 100% | 127.53 | 577 / 578 | 41% | 1.65 | 478 / 1155 |
| esophagus | 89% | 54.74 | 1293 / 1445 | 37% | 1.77 | 68 / 183 |
| adrenal gland | 72% | 34.26 | 187 / 258 | 54% | 4.01 | 124 / 230 |
| uterus | 99% | 171.37 | 169 / 170 | 27% | 1.62 | 123 / 459 |
| skin | 87% | 50.87 | 1565 / 1809 | 34% | 2.24 | 159 / 472 |
| thymus | 99% | 79.61 | 644 / 653 | 21% | 0.49 | 130 / 605 |
| bladder | 100% | 99.48 | 21 / 21 | 17% | 0.53 | 88 / 504 |
| intestine | 95% | 80.01 | 922 / 966 | 17% | 0.70 | 90 / 527 |
| stomach | 79% | 46.03 | 283 / 359 | 27% | 0.81 | 76 / 286 |
| adipose | 100% | 132.97 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 99% | 85.46 | 1325 / 1335 | 0% | 0 | 0 / 0 |
| heart | 97% | 74.43 | 832 / 861 | 0% | 0 | 0 / 0 |
| muscle | 85% | 35.12 | 681 / 803 | 0% | 0 | 0 / 0 |
| spleen | 83% | 35.61 | 199 / 241 | 0% | 0 | 0 / 0 |
| liver | 8% | 2.23 | 18 / 226 | 14% | 0.66 | 56 / 406 |
| tonsil | 0% | 0 | 0 / 0 | 13% | 0.52 | 6 / 45 |
| eye | 0% | 0 | 0 / 0 | 11% | 0.29 | 9 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0007416 | Biological process | synapse assembly |
| GO_0007399 | Biological process | nervous system development |
| GO_0007156 | Biological process | homophilic cell adhesion via plasma membrane adhesion molecules |
| GO_0007155 | Biological process | cell adhesion |
| GO_0007268 | Biological process | chemical synaptic transmission |
| GO_0016339 | Biological process | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules |
| GO_0045202 | Cellular component | synapse |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0016020 | Cellular component | membrane |
| GO_0005509 | Molecular function | calcium ion binding |
| GO_0005515 | Molecular function | protein binding |
| Gene name | PCDHB3 |
| Protein name | Protocadherin beta 3 Protocadherin beta-3 (PCDH-beta-3) Protocadherin beta 2 (Protocadherin beta 3) |
| Synonyms | PCDHB2 |
| Description | FUNCTION: Potential calcium-dependent cell-adhesion protein. May be involved in the establishment and maintenance of specific neuronal connections in the brain. |
| Accessions | ENST00000624994.1 ENST00000231130.3 A0A096LPA4 Q9Y5E6 Q2M3R2 ENST00000624513.1 |